
Senior Director, Strategic Initiatives @INBT_JHU Adjunct Professor @JHUArtsSciences
Baltimore, MD
Joined August 2017
- Tweets248
- Following170
- Followers203
- Likes533
Replying to @OrgenesisInc
@OrgenesisInc secures $50 million subsidiary-level investment from Metalmark Capital to grow Point-of-Care Services subsidiary, Morgenesis. Will use for further #POCare #platform rollout. Orgenesis selected Metalmark for #pharma #investment success. tinyurl.com/ywpca23n
Luke Thorstenson retweeted
Our CEO Ms Vered Caplan sat down with @ScienceBoard at the @ISCTglobal Annual Meeting 2022, to discuss how we can #simplify and #lowercosts of providing #CGT. Vered enjoyed talking to @waltschoenborn, in this interview, which you can see here: lnkd.in/eitdws3t
Luke Thorstenson retweeted
The Orgenesis team are excited to be part of the @ISCTglobal Annual Meeting, in San Francisco. Bringing you the Symphonia Phonotone show at the Presidential Reception & 30th Anniversary Celebration, May 4, 18:00 - 20.00 (PST). Come along, meet us & hear from our CEO, Vered Caplan

ALT The Orgenesis team are excited to be a part of the ISCT Annual Meeting, in San Francisco next week. We will be bringing you the Symphonia Phonotone show at the Presidential Reception & 30th Anniversary Celebration, May 4, 18:00 - 20.00 (PST). Come along to meet our team and hear from our CEO, Vered Caplan.
Luke Thorstenson retweeted
Orgenesis Reports Revenue Growth of 364% for 2021 and Provides Business Update
ir.orgenesis.com/press-relea…
$ORGS
Luke Thorstenson retweeted
Orgenesis completed the placement of an OMPUL on site, at the Hospital Infantil Universitario Niño Jesús in Madrid
The OMPUL is the first in Europe that has been designed specifically to process TILs and MSCs
Press Release:
ir.orgenesis.com/press-relea…
$ORGS #TILs #MSCs
Luke Thorstenson retweeted
Orgenesis and @JohnsHopkins expand POCare in Maryland through creation of the Maryland Center for Cell Therapy Manufacturing
The New Center will expand Orgenesis’ Point of Care (POCare) Platform Capabilities in Maryland
orgenesis.com/press-release-… $ORGS
Excited for my first face to face conference in 18 months! #IOSummit lnkd.in/dk39Qz9j
Luke Thorstenson retweeted
We’re excited to be a part of the upcoming Immuno-Oncology Summit in Boston. Our Scientific Director of #ImmunoOncology, Eyal Neria, will be presenting on ‘Utilizing point of care processing for adoptive #CellTherapy.'
Learn more: bit.ly/2ZgG3xa
Luke Thorstenson retweeted
Orgenesis Tackles Cell Therapy Costs, Barriers With Decentralized Model ow.ly/2fnT102SqNE
Cell & gene therapy has an accessibility problem. This insightful article discusses several potential solutions, including our automated, closed & flexible Orgenesis Mobile Production Units and Labs (OMPULs) @OrgenesisInc @avrobio @OriBiotech @Cytiva fiercepharma.com/manufacturi…
Luke Thorstenson retweeted
We are just a couple of weeks away from the 14th Annual Nano-Bio Symposium featuring #INBTageneers @AshaniTW, @GerechtLab, @JudeM_Phillip, @deniswirtz and more! Are you registered yet? Tickets are free! inbt.jhu.edu/engineering-in-…
#HopkinsEngineer
Luke Thorstenson retweeted
3 key points for folks recently vaccinated with J&J
1. your risk of getting hit by lightning this year > your risk of developing blood clot from vaccine
2. Don't ignore a new severe headache, abd pain, or shortness of breath
3. Enjoy being vaccinated against a deadly disease
Luke Thorstenson retweeted
Click here to take our brief survey! bddy.me/3suLfr0
Luke Thorstenson retweeted
Please retweet:
Our Johns Hopkins led study wants to learn more about COVID-19 symptoms in the short and long term.
Tell us more about what you experienced by filling out a short (10min), online questionnaire at covid-long.com
@washingtonpost @NPRHealth @Newsweek @TIME
Fantastic news to start the day! @ThriveDetect, a company spun out of @JohnsHopkins @HopkinsEngineer @HopkinsMedicine was acquired in a cash/stock deal worth up to $2.15B! @ExactSciences
Today, we're pleased to announce @ExactSciences has agreed to acquire Thrive. Together we can accelerate our mission of detecting more cancers at earlier stages when it can be more effectively treated, and in many cases, cured. thrivedetect.com/press-relea…
Luke Thorstenson retweeted
Congratulations! We are thrilled to have so many Siebel Scholars on board at INBT! Read more about the talented and inspiring recipients of the #SiebelScholar award in today’s issue of @HubJHU:
hub.jhu.edu/2020/09/29/siebe…
#bioengineering #womeninSTEM
Thanks for the shout out @JGreenGroup! What an exciting day! We (@INBT_JHU) are always happy to provide support to our amazing faculty. We look forward to tracking the continued success of @AsclepiX_Tx
Congrats to the awesome team! We look forward to #InventingTheFutureOfMedicine and restoring vision! Would like to especially thank those that supported us & #BME #innovation since the beginning: @JHUBME #WallaceCoulter @MDTEDCO @JHTechVentures @NIHsbir #icorps @TTECJHU @INBT_JHU
Luke Thorstenson retweeted
Professors, Graduate School Directors, Dept. Chairs, PIs, Postdocs and white graduate students.
Please take a few minutes to read stories from #BlackintheIvory
We are telling our stories. True allies should be willing to listen.
















